RMTG
Regenerative Medical Technology Group Inc.
Mentions (24Hr)
0.00% Today
Reddit Posts
🎙️ RMTG Featured on Sully Sullivan + Puerto Rico Expansion – Major Momentum!
Mentions
RMTG's strategy seems designed to create recurring engagement with physicians rather than one-time transactions. Educational programs, certifications, and ongoing product support can all contribute to longer-term relationships. That type of model can become more valuable as the network grows.
The ISSCA Global Summit solidified RMTG’s standing as a global education leader in regenerative medicine, with 30+ countries represented. That’s serious traction.
When a company draws medical professionals from every continent to a single event, you know they’re leading in something important. RMTG’s global reach is expanding fast.
From registration income to product showcases, RMTG turned an educational event into a multi-channel revenue generator — a sign of smart execution.
The ISSCA summit in Cancún marks a pivotal milestone for RMTG. Their reach across 30+ nations shows their ecosystem has matured into a true global network.
Conor McGregor helped catapult UFC into global dominance, and now he’s doing the same for BKFC. RMTG is positioned at the center of that story.
McGregor’s association with BKFC guarantees fans, fighters, and investors will be watching closely. RMTG is perfectly placed to capitalize on that attention.
RMTG is building for longevity — literally. Their therapies target orthopedics, neurology, aesthetics, and anti-aging, all massive growth sectors.
This expansion gives RMTG a chance to capture demand from the booming longevity and regenerative medicine sectors.
By January 2026, Cancun will be at full scale. RMTG investors have a clear, near-term operational catalyst.
The Cancun lab gives $RMTG something most small biotech names never achieve — fully licensed manufacturing capacity for stem cells, exosomes, and NK cells. That’s real infrastructure for real growth.
RMTG’s focus on both production and physician training ensures it captures revenue at multiple levels of the regenerative medicine value chain.
RMTG is building infrastructure that creates both immediate revenue (training) and long-term recurring income (cell banking and therapies).
By honoring its vendor relationships, RMTG is proving it understands the importance of reliability. Strong partnerships translate into strong performance across the board.
RMTG is successfully moving through its year-end audit, proving that discipline and accountability remain central to its operations. Staying on schedule for the 10-K filing is a major sign of stability and commitment to shareholders.
RMTG is a private, reputation-based trading network built for serious people only. Every member is vetted. Every deal is tracked. If you're tired of unreliable servers, this is your next move.
RMTG posted 67% YoY Q1 growth, and this expansion strengthens the flywheel: affiliate fees, product sales, and scalable infrastructure.
During the ISSCA conference in Buenos Aires, RMTG announced Puerto Rico as its next milestone—a move that signals strong Caribbean and Central American intent.
With leadership from Ramos and Nieves, RMTG adds true clinical talent and credibility to its Puerto Rico operation. This isn’t a license deal—it’s boots on the ground.
RMTG continues its aggressive growth strategy with Puerto Rico now part of its 26-clinic global network. This isn't a press release—it's execution.
The new affiliate follows RMTG’s proven turnkey model: upfront 6-figure fees + exclusive Cellgenic product purchases = strong recurring revenue.
The Puerto Rico healthcare market is valued at $4.2B. RMTG’s entry here is not just strategic—it’s a long-term revenue gateway.
That Cancun clinic is just the beginning. Global footprint growing fast. $RMTG.
Sales up. Clinics up. Margins up. $RMTG has something real going.
I don’t buy hype — I buy profit and growth. $RMTG just posted both.
Revenue, profit, and a brand new recurring revenue stream. $RMTG moving on all fronts.
This wasn’t just a strong quarter. It’s a strategic shift into scale mode. $RMTG.
RMTG looks like a Hem 12.5m share float. $4.1m in rev 2024-70% YoY growth-70% gross margins. 26 clinics in 21 countries. 2 more in Dubai/Cancun coming. Also CEO led a successful NASDAQ IPO with plans to do same with RMTG
This board just recycles the same 12 tickers like a broken record.—yawn. Where’s the original DD? The under-the-radar plays? Fine, I’ll bite. I’ll take a small position in $ITRM just to see if the buyout fairy shows up. But if this flops, I’m dragging you clowns. 🚀 $AITX+$RMTG + $ITRM (for the lolz). Let’s ride.